Adverse effect | Appointment type | Number of dogs | Total Dogs | Percentage (%) |
---|---|---|---|---|
VT/VA-observed adverse reactions at the clinic | ||||
 All adverse reactions |  | 483 | 539 | 90 |
 | Injection 1 | 366 | 479 | 76 |
 | Injection 2 | 354 | 518 | 68 |
 | Injection 3 | 288 | 468 | 62 |
 Behavioral |  | 465 | 539 | 86 |
 | Injection 1 | 340 | 478 | 71 |
 | Injection 2 | 342 | 518 | 63 |
 | Injection 3 | 243 | 468 | 52 |
 Local injection site |  | 177 | 539 | 33 |
 | Injection 1 | 80 | 477 | 17 |
 | Injection 2 | 67 | 515 | 13 |
 | Injection 3 | 92 | 468 | 20 |
 Respiratory |  | 3 | 539 | 0.6 |
 | Injection 1 | 1 | 477 | 0.2 |
 | Injection 2 | 2 | 515 | 0.4 |
 | Injection 3 | 1 | 468 | 0.2 |
 Gastrointestinal |  | 16 | 539 | 3.0 |
 | Injection 1 | 3 | 477 | 0.6 |
 | Injection 2 | 7 | 515 | 1.4 |
 | Injection 3 | 6 | 468 | 1.3 |
 Immediate hypersensitivity |  | 1 | 539 | 0.2 |
 | Injection 1 | 0 | 477 | 0 |
 | Injection 2 | 1 | 515 | 0.2 |
 | Injection 3 | 0 | 468 | 0 |
Owner-observed adverse reactions 10 days following a melarsomine injection | ||||
 All adverse reactions |  | 314 | 539 | 58 |
 | Injection 1 | 244 | 505 | 48 |
 | Injections 2/3 | 186 | 389 | 48 |
 Behavioral |  | 166 | 539 | 31 |
 | Injection 1 | 125 | 467 | 27 |
 | Injections 2/3 | 81 | 349 | 23 |
 Local injection site |  | 215 | 539 | 40 |
 | Injection 1 | 156 | 502 | 31 |
 | Injections 2/3 | 130 | 367 | 35 |
 Respiratory |  | 104 | 539 | 19 |
 | Injection 1 | 78 | 503 | 16 |
 | Injections 2/3 | 55 | 388 | 14 |
 Gastrointestinal |  | 136 | 539 | 25 |
 | Injection 1 | 93 | 467 | 20 |
 | Injections 2/3 | 73 | 349 | 21 |